Loading…

CCR4 1014C/T and CCL22 16C/A Genetic Variations in Iranian Patients with Thyroid Cancer

Background: The aim of this study was to investigate the association between thyroid cancer and 16C/A single nucleotide polymorphism (SNP) in C-C motif chemokine 22 (CCL22) as well as 1014C/T SNP in C-C chemokine receptor type 4 (CCR4).Method: In this case-control study, polymerase chain reaction re...

Full description

Saved in:
Bibliographic Details
Published in:Middle East journal of cancer 2022-07, Vol.13 (3), p.404-410
Main Authors: Mohammad Hossein Dabbaghmanesh, Bahare Rezaei, Mohammad Reza Haghshenas, Nima Montazeri-Najafabady, Rajeeh Mohammadian Amiri, Nasrollah Erfani
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 410
container_issue 3
container_start_page 404
container_title Middle East journal of cancer
container_volume 13
creator Mohammad Hossein Dabbaghmanesh
Bahare Rezaei
Mohammad Reza Haghshenas
Nima Montazeri-Najafabady
Rajeeh Mohammadian Amiri
Nasrollah Erfani
description Background: The aim of this study was to investigate the association between thyroid cancer and 16C/A single nucleotide polymorphism (SNP) in C-C motif chemokine 22 (CCL22) as well as 1014C/T SNP in C-C chemokine receptor type 4 (CCR4).Method: In this case-control study, polymerase chain reaction restriction-fragment length polymorphism (PCR-RFLP) was performed for 113 thyroid cancer patients and 112 age-sex matched healthy controls to investigate the genotype distribution.Results: At position 16C/A in CCL22, 95 patients (84.3%) were found to have CC genotype, while 17 individuals (14.8%) inherited CA genotype and 1 (0.9%) had AA genotype. In the control group, 92 volunteers (82.1%) inherited CC genotype, 18 individuals (16.1%) had CA genotype, and 2 (1.8%) had AA genotype. The frequency of CC, CT, and TT genotypes of 1014C/T SNP in CCR4 gene was 60 (53.1%), 43 (38.1%), and 10 (8.8%) in the patients, and 57 (53.3%), 43 (40.2%), and 7 (6.5%) in the control group, respectively. There were no statistically significant differences between the patients and controls in terms of 16C/A polymorphism in CCL22 (P = 0.816) and 1014C/T SNP in CCR4 1014C/T gene position (P = 0.801). Nevertheless, the study of their association indicated that inheriting the CC genotype of CCR4 was significantly associated with higher stages (stages 3 and 4) in thyroid cancer.Conclusion: 1014C/T genetic variation in CCR4 and 16C/A polymorphism in CCL22 were not found to have a role in genetic susceptibility to thyroid cancer. Inheriting CC genotype at 1014 locus in CCR4 may; however, affect cancer progression in patients with thyroid cancer.
doi_str_mv 10.30476/mejc.2021.87469.1421
format article
fullrecord <record><control><sourceid>doaj</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_fcd60cd644254b739493cdec037d81a4</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_fcd60cd644254b739493cdec037d81a4</doaj_id><sourcerecordid>oai_doaj_org_article_fcd60cd644254b739493cdec037d81a4</sourcerecordid><originalsourceid>FETCH-LOGICAL-d151t-9e5e717224edeeb66fc72fc167273d1c85e550a4e8ee3842daec5019a2f166be3</originalsourceid><addsrcrecordid>eNo1T9tKAzEUDKJg0X6CkB_YbU6SzeWxBK2FgiJVH5c0OWtT2qxkF6R_7-JlYJhhYAaGkDtgtWBSq8UJD6HmjENttFS2Bsnhgsw4Y6ZSyujLf6-ZvSbzYTiwCcIqq8WMvDv3IikwkG6xpT5H6tyGcwrKLZZ0hRnHFOibL8mPqc8DTZmui8_JZ_o8RZjHgX6lcU-3-3Pp09T3OWC5JVedPw44_9Mb8vpwv3WP1eZptXbLTRWhgbGy2KAGzbnEiLhTqguadwGU5lpECKbBpmFeokEURvLoMTQMrOcdKLVDcUPWv7ux94f2s6STL-e296n9Cfry0foyXThi24Wo2EQpeSN3WlhpRYgYmNDRgJfiGwZJX0U</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>CCR4 1014C/T and CCL22 16C/A Genetic Variations in Iranian Patients with Thyroid Cancer</title><source>EZB Electronic Journals Library</source><creator>Mohammad Hossein Dabbaghmanesh ; Bahare Rezaei ; Mohammad Reza Haghshenas ; Nima Montazeri-Najafabady ; Rajeeh Mohammadian Amiri ; Nasrollah Erfani</creator><creatorcontrib>Mohammad Hossein Dabbaghmanesh ; Bahare Rezaei ; Mohammad Reza Haghshenas ; Nima Montazeri-Najafabady ; Rajeeh Mohammadian Amiri ; Nasrollah Erfani</creatorcontrib><description>Background: The aim of this study was to investigate the association between thyroid cancer and 16C/A single nucleotide polymorphism (SNP) in C-C motif chemokine 22 (CCL22) as well as 1014C/T SNP in C-C chemokine receptor type 4 (CCR4).Method: In this case-control study, polymerase chain reaction restriction-fragment length polymorphism (PCR-RFLP) was performed for 113 thyroid cancer patients and 112 age-sex matched healthy controls to investigate the genotype distribution.Results: At position 16C/A in CCL22, 95 patients (84.3%) were found to have CC genotype, while 17 individuals (14.8%) inherited CA genotype and 1 (0.9%) had AA genotype. In the control group, 92 volunteers (82.1%) inherited CC genotype, 18 individuals (16.1%) had CA genotype, and 2 (1.8%) had AA genotype. The frequency of CC, CT, and TT genotypes of 1014C/T SNP in CCR4 gene was 60 (53.1%), 43 (38.1%), and 10 (8.8%) in the patients, and 57 (53.3%), 43 (40.2%), and 7 (6.5%) in the control group, respectively. There were no statistically significant differences between the patients and controls in terms of 16C/A polymorphism in CCL22 (P = 0.816) and 1014C/T SNP in CCR4 1014C/T gene position (P = 0.801). Nevertheless, the study of their association indicated that inheriting the CC genotype of CCR4 was significantly associated with higher stages (stages 3 and 4) in thyroid cancer.Conclusion: 1014C/T genetic variation in CCR4 and 16C/A polymorphism in CCL22 were not found to have a role in genetic susceptibility to thyroid cancer. Inheriting CC genotype at 1014 locus in CCR4 may; however, affect cancer progression in patients with thyroid cancer.</description><identifier>ISSN: 2008-6709</identifier><identifier>EISSN: 2008-6687</identifier><identifier>DOI: 10.30476/mejc.2021.87469.1421</identifier><language>eng</language><publisher>Shiraz University of Medical Sciences</publisher><subject>cancer progression ; cc chemokine receptor 4 ; ccl22 chemokine ; genetic variations ; single nucleotide polymorphism ; thyroid cancer</subject><ispartof>Middle East journal of cancer, 2022-07, Vol.13 (3), p.404-410</ispartof><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Mohammad Hossein Dabbaghmanesh</creatorcontrib><creatorcontrib>Bahare Rezaei</creatorcontrib><creatorcontrib>Mohammad Reza Haghshenas</creatorcontrib><creatorcontrib>Nima Montazeri-Najafabady</creatorcontrib><creatorcontrib>Rajeeh Mohammadian Amiri</creatorcontrib><creatorcontrib>Nasrollah Erfani</creatorcontrib><title>CCR4 1014C/T and CCL22 16C/A Genetic Variations in Iranian Patients with Thyroid Cancer</title><title>Middle East journal of cancer</title><description>Background: The aim of this study was to investigate the association between thyroid cancer and 16C/A single nucleotide polymorphism (SNP) in C-C motif chemokine 22 (CCL22) as well as 1014C/T SNP in C-C chemokine receptor type 4 (CCR4).Method: In this case-control study, polymerase chain reaction restriction-fragment length polymorphism (PCR-RFLP) was performed for 113 thyroid cancer patients and 112 age-sex matched healthy controls to investigate the genotype distribution.Results: At position 16C/A in CCL22, 95 patients (84.3%) were found to have CC genotype, while 17 individuals (14.8%) inherited CA genotype and 1 (0.9%) had AA genotype. In the control group, 92 volunteers (82.1%) inherited CC genotype, 18 individuals (16.1%) had CA genotype, and 2 (1.8%) had AA genotype. The frequency of CC, CT, and TT genotypes of 1014C/T SNP in CCR4 gene was 60 (53.1%), 43 (38.1%), and 10 (8.8%) in the patients, and 57 (53.3%), 43 (40.2%), and 7 (6.5%) in the control group, respectively. There were no statistically significant differences between the patients and controls in terms of 16C/A polymorphism in CCL22 (P = 0.816) and 1014C/T SNP in CCR4 1014C/T gene position (P = 0.801). Nevertheless, the study of their association indicated that inheriting the CC genotype of CCR4 was significantly associated with higher stages (stages 3 and 4) in thyroid cancer.Conclusion: 1014C/T genetic variation in CCR4 and 16C/A polymorphism in CCL22 were not found to have a role in genetic susceptibility to thyroid cancer. Inheriting CC genotype at 1014 locus in CCR4 may; however, affect cancer progression in patients with thyroid cancer.</description><subject>cancer progression</subject><subject>cc chemokine receptor 4</subject><subject>ccl22 chemokine</subject><subject>genetic variations</subject><subject>single nucleotide polymorphism</subject><subject>thyroid cancer</subject><issn>2008-6709</issn><issn>2008-6687</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNo1T9tKAzEUDKJg0X6CkB_YbU6SzeWxBK2FgiJVH5c0OWtT2qxkF6R_7-JlYJhhYAaGkDtgtWBSq8UJD6HmjENttFS2Bsnhgsw4Y6ZSyujLf6-ZvSbzYTiwCcIqq8WMvDv3IikwkG6xpT5H6tyGcwrKLZZ0hRnHFOibL8mPqc8DTZmui8_JZ_o8RZjHgX6lcU-3-3Pp09T3OWC5JVedPw44_9Mb8vpwv3WP1eZptXbLTRWhgbGy2KAGzbnEiLhTqguadwGU5lpECKbBpmFeokEURvLoMTQMrOcdKLVDcUPWv7ux94f2s6STL-e296n9Cfry0foyXThi24Wo2EQpeSN3WlhpRYgYmNDRgJfiGwZJX0U</recordid><startdate>20220701</startdate><enddate>20220701</enddate><creator>Mohammad Hossein Dabbaghmanesh</creator><creator>Bahare Rezaei</creator><creator>Mohammad Reza Haghshenas</creator><creator>Nima Montazeri-Najafabady</creator><creator>Rajeeh Mohammadian Amiri</creator><creator>Nasrollah Erfani</creator><general>Shiraz University of Medical Sciences</general><scope>DOA</scope></search><sort><creationdate>20220701</creationdate><title>CCR4 1014C/T and CCL22 16C/A Genetic Variations in Iranian Patients with Thyroid Cancer</title><author>Mohammad Hossein Dabbaghmanesh ; Bahare Rezaei ; Mohammad Reza Haghshenas ; Nima Montazeri-Najafabady ; Rajeeh Mohammadian Amiri ; Nasrollah Erfani</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-d151t-9e5e717224edeeb66fc72fc167273d1c85e550a4e8ee3842daec5019a2f166be3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>cancer progression</topic><topic>cc chemokine receptor 4</topic><topic>ccl22 chemokine</topic><topic>genetic variations</topic><topic>single nucleotide polymorphism</topic><topic>thyroid cancer</topic><toplevel>online_resources</toplevel><creatorcontrib>Mohammad Hossein Dabbaghmanesh</creatorcontrib><creatorcontrib>Bahare Rezaei</creatorcontrib><creatorcontrib>Mohammad Reza Haghshenas</creatorcontrib><creatorcontrib>Nima Montazeri-Najafabady</creatorcontrib><creatorcontrib>Rajeeh Mohammadian Amiri</creatorcontrib><creatorcontrib>Nasrollah Erfani</creatorcontrib><collection>Directory of Open Access Journals</collection><jtitle>Middle East journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mohammad Hossein Dabbaghmanesh</au><au>Bahare Rezaei</au><au>Mohammad Reza Haghshenas</au><au>Nima Montazeri-Najafabady</au><au>Rajeeh Mohammadian Amiri</au><au>Nasrollah Erfani</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CCR4 1014C/T and CCL22 16C/A Genetic Variations in Iranian Patients with Thyroid Cancer</atitle><jtitle>Middle East journal of cancer</jtitle><date>2022-07-01</date><risdate>2022</risdate><volume>13</volume><issue>3</issue><spage>404</spage><epage>410</epage><pages>404-410</pages><issn>2008-6709</issn><eissn>2008-6687</eissn><abstract>Background: The aim of this study was to investigate the association between thyroid cancer and 16C/A single nucleotide polymorphism (SNP) in C-C motif chemokine 22 (CCL22) as well as 1014C/T SNP in C-C chemokine receptor type 4 (CCR4).Method: In this case-control study, polymerase chain reaction restriction-fragment length polymorphism (PCR-RFLP) was performed for 113 thyroid cancer patients and 112 age-sex matched healthy controls to investigate the genotype distribution.Results: At position 16C/A in CCL22, 95 patients (84.3%) were found to have CC genotype, while 17 individuals (14.8%) inherited CA genotype and 1 (0.9%) had AA genotype. In the control group, 92 volunteers (82.1%) inherited CC genotype, 18 individuals (16.1%) had CA genotype, and 2 (1.8%) had AA genotype. The frequency of CC, CT, and TT genotypes of 1014C/T SNP in CCR4 gene was 60 (53.1%), 43 (38.1%), and 10 (8.8%) in the patients, and 57 (53.3%), 43 (40.2%), and 7 (6.5%) in the control group, respectively. There were no statistically significant differences between the patients and controls in terms of 16C/A polymorphism in CCL22 (P = 0.816) and 1014C/T SNP in CCR4 1014C/T gene position (P = 0.801). Nevertheless, the study of their association indicated that inheriting the CC genotype of CCR4 was significantly associated with higher stages (stages 3 and 4) in thyroid cancer.Conclusion: 1014C/T genetic variation in CCR4 and 16C/A polymorphism in CCL22 were not found to have a role in genetic susceptibility to thyroid cancer. Inheriting CC genotype at 1014 locus in CCR4 may; however, affect cancer progression in patients with thyroid cancer.</abstract><pub>Shiraz University of Medical Sciences</pub><doi>10.30476/mejc.2021.87469.1421</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2008-6709
ispartof Middle East journal of cancer, 2022-07, Vol.13 (3), p.404-410
issn 2008-6709
2008-6687
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_fcd60cd644254b739493cdec037d81a4
source EZB Electronic Journals Library
subjects cancer progression
cc chemokine receptor 4
ccl22 chemokine
genetic variations
single nucleotide polymorphism
thyroid cancer
title CCR4 1014C/T and CCL22 16C/A Genetic Variations in Iranian Patients with Thyroid Cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T23%3A58%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-doaj&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CCR4%201014C/T%20and%20CCL22%2016C/A%20Genetic%20Variations%20in%20Iranian%20Patients%20with%20Thyroid%20Cancer&rft.jtitle=Middle%20East%20journal%20of%20cancer&rft.au=Mohammad%20Hossein%20Dabbaghmanesh&rft.date=2022-07-01&rft.volume=13&rft.issue=3&rft.spage=404&rft.epage=410&rft.pages=404-410&rft.issn=2008-6709&rft.eissn=2008-6687&rft_id=info:doi/10.30476/mejc.2021.87469.1421&rft_dat=%3Cdoaj%3Eoai_doaj_org_article_fcd60cd644254b739493cdec037d81a4%3C/doaj%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-d151t-9e5e717224edeeb66fc72fc167273d1c85e550a4e8ee3842daec5019a2f166be3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true